Loading resource…

Brigham and Women’s Hospital, Harvard Medical School, and various other institutions
The guideline addresses the diagnostic criteria for primary aldosteronism, including the use of plasma and urinary steroid profiling. It discusses treatment options, including medical therapy with mineralocorticoid receptor antagonists and surgical interventions for patients with lateralizing forms of the disease. The document also emphasizes the importance of monitoring cardiovascular outcomes in patients with PA and provides a framework for clinical decision-making based on the latest research findings.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology

Kiruddu DKA guidelines
Same clinical topic · Endocrinology

Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology

Management of DKA
Same clinical topic · Endocrinology

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology

GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology

2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology

CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology

Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology